Listen to Dr. Julia Kirshner, founder and CEO of zPREDICTA, discuss tumor-specific 3D culture models that reconstruct the native microenvironment of human tissues for more accurate testing of pharmaceutical compounds. Discover how the D300e enabled zPREDICTA’s models to be successfully adopted for testing in high throughput format.